Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Simson Jake Insider Profile
4 Followers
Simson Jake, Director at Janux Therapeutics Inc, holds 2.50K shares in Janux Therapeutics Inc (Ticker: JANX), holds ― shares in Dice Therapeutics (Ticker: DICE), holds ― shares in Tyra Bioscience (Ticker: TYRA).
Simson Jake has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Simson Jake holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Simson Jake
Simson Jake's Trading History
Janux Therapeutics Inc
Jun 28, 2024
Director
Uninformative Buy
―
$111.70K
Dice Therapeutics
―
―
―
―
Tyra Bioscience
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Simson Jake's performance on stock
You May Also Like
Simson Jake insider profile FAQ
What is the percentage of profitable transactions made by Simson Jake?
The percentage of profitable transactions made by Simson Jake is ―.
What is the average return per transaction made by Simson Jake?
The average return per transaction made by Simson Jake is ―.
What stocks does Simson Jake hold?
Simson Jake holds: JANX, DICE, TYRA stocks.
What was Simson Jake’s latest transaction?
Simson Jake latest transaction was an Uninformative Buy of ―.
What was Simson Jake's most profitable transaction?
Simson Jake’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Simson Jake's role in Janux Therapeutics Inc?
Simson Jake's role in Janux Therapeutics Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.